Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone D'adamio

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Expert Opinion on Biological Therapy|April 7, 2022
Guselkumab for the treatment of psoriasis: a 60-week real-life multicenter retrospective experienceFederico Bardazzi, Filippo Viviani, Yuri Merli, et al.
Italian Journal of Dermatology and Venereology|September 21, 2021
Use of Apremilast® in the psoriasis treatment: a real-life multicenter Italian experienceFederica Filippi, Annalisa Patrizi, Luca Iezzi, et al.
Dermatology Practical & Conceptual|August 9, 2024
Real Life Comparative Effectiveness of IL-23 Inhibitors in the Treatment of Moderate to Severe Psoriasis: A Multicenter ExperienceAlessandro Borghi, Giulia Odorici, Federico Bardazzi, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Expert Opinion on Biological Therapy|April 7, 2022
Guselkumab for the treatment of psoriasis: a 60-week real-life multicenter retrospective experienceFederico Bardazzi, Filippo Viviani, Yuri Merli, et al.
Italian Journal of Dermatology and Venereology|September 21, 2021
Use of Apremilast® in the psoriasis treatment: a real-life multicenter Italian experienceFederica Filippi, Annalisa Patrizi, Luca Iezzi, et al.
Dermatology Practical & Conceptual|August 9, 2024
Real Life Comparative Effectiveness of IL-23 Inhibitors in the Treatment of Moderate to Severe Psoriasis: A Multicenter ExperienceAlessandro Borghi, Giulia Odorici, Federico Bardazzi, et al.
Pageof 2